BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35120467)

  • 1. Somatic mutations in collagens are associated with a distinct tumor environment and overall survival in gastric cancer.
    Brodsky AS; Khurana J; Guo KS; Wu EY; Yang D; Siddique AS; Wong IY; Gamsiz Uzun ED; Resnick MB
    BMC Cancer; 2022 Feb; 22(1):139. PubMed ID: 35120467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
    Li X; Pasche B; Zhang W; Chen K
    JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Highly Expressed Type VII Collagen (COL7A1) in Patients With Gastric Cancer.
    Oh SE; Oh MY; An JY; Lee JH; Sohn TS; Bae JM; Choi MG; Kim KM
    Pathol Oncol Res; 2021; 27():1609860. PubMed ID: 34512204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
    Qiu H; Zhang X; Yu H; Gao R; Shi J; Shen T
    Bioengineered; 2021 Dec; 12(1):4304-4319. PubMed ID: 34348580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiscale network analysis reveals molecular mechanisms and key regulators of the tumor microenvironment in gastric cancer.
    Song WM; Lin X; Liao X; Hu D; Lin J; Sarpel U; Ye Y; Feferman Y; Labow DM; Walsh MJ; Zheng X; Zhang B
    Int J Cancer; 2020 Mar; 146(5):1268-1280. PubMed ID: 31463974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
    Ren N; Liang B; Li Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor collagens predict genetic features and patient outcomes.
    Guo KS; Brodsky AS
    NPJ Genom Med; 2023 Jul; 8(1):15. PubMed ID: 37414817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
    Hu X; Wu L; Liu B; Chen K
    Front Immunol; 2021; 12():651056. PubMed ID: 34122409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer.
    Ran T; Chen Z; Zhao L; Ran W; Fan J; Hong S; Yang Z
    Technol Cancer Res Treat; 2021; 20():15330338211004944. PubMed ID: 33784890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
    Manzano RG; Catalan-Latorre A; Brugarolas A
    BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of p21 and Her-2 gene expression and mutation/polymorphism in patients with gastric adenocarcinoma.
    Ozen A; Kocak Z; Sipahi T; Oz-Puyan F; Cakina S; Saynak M; Ibis C; Karagol H
    Med Oncol; 2013 Mar; 30(1):357. PubMed ID: 23275116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis.
    Kalady MF; Dejulius KL; Sanchez JA; Jarrar A; Liu X; Manilich E; Skacel M; Church JM
    Dis Colon Rectum; 2012 Feb; 55(2):128-33. PubMed ID: 22228154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
    Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
    Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline genetic variants were interactively associated with somatic alterations in gastric cancer.
    Zhang X; Wang Y; Tian T; Zhou G; Jin G
    Cancer Med; 2018 Aug; 7(8):3912-3920. PubMed ID: 29923336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mutational profiles of stage II and III gastric cancer according to tumor microenvironment immune type.
    Koh J; Nam SK; Roh H; Kim J; Lee BC; Kim JW; Ahn SH; Park DJ; Kim HH; Park KU; Chung JH; Kim WH; Lee HS
    Genes Chromosomes Cancer; 2019 Jan; 58(1):12-22. PubMed ID: 30239046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.
    Kim A; Lim SM; Kim JH; Seo JS
    Front Immunol; 2021; 12():598671. PubMed ID: 33717076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer.
    Yu Y; Xie Z; Zhao M; Lian X
    BMC Cancer; 2021 Apr; 21(1):368. PubMed ID: 33827485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite Instability Analysis in Gastric Carcinomas of Moroccan Patients.
    Nshizirungu JP; Bennis S; Mellouki I; Benajah DA; Lahmidani N; El Bouhaddoutti H; Ibn Majdoub K; Ibrahimi SA; Pires Celeiro S; Viana-Pereira M; Manuel Reis R
    Genet Test Mol Biomarkers; 2021 Feb; 25(2):116-123. PubMed ID: 33596142
    [No Abstract]   [Full Text] [Related]  

  • 20. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
    Tsuruta S; Ohishi Y; Fujiwara M; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
    Hum Pathol; 2019 Jun; 88():27-38. PubMed ID: 30946937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.